Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：6.832 Date：2022-02-10

Bioengineered

Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model

Products： ELK1132、 ELK1660
IF：6.8 Date：2024-02-14

Cell and Tissue Research

Long noncoding RNA XIST inhibition promotes Leydig cell apoptosis by acting as a competing endogenous RNA for microRNA-145a-5p that targets SIRT1 in late-onset hypogonadism

Products： ELK9209
IF：6.8 Date：2025-04-17

Journal of Xenobiotics

Serum and Cerebrospinal Fluid Malondialdehyde Levels in Patients with Mild Cognitive Impairment

Products： ELK7832
IF：6.7 Date：2024-07-25

Phytomedicine

Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinoma

Products：

< Page of 352 >